Rockwell Medical (RMTI) Capital Expenditures Growth (3y) (2013 - 2026)
Powered by 
Analysis
Rockwell Medical (RMTI) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | -9.20% |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | -16.94% |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | -10.72% |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 12.61% |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | -12.05% |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 97.57% |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | -30.50% |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 97.57% |
| Mar 31, 2026 | 43.11% |
| Dec 31, 2025 | -32.61% |
| Sep 30, 2025 | 69.42% |
| Jun 30, 2025 | 47.60% |
| Mar 31, 2025 | 29.51% |
| Dec 31, 2024 | 51.32% |
| Sep 30, 2024 | 14.57% |
| Jun 30, 2024 | 5.58% |
| Mar 31, 2024 | 54.08% |
| Dec 31, 2023 | -17.29% |
| Sep 30, 2023 | -71.44% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -10.61% |
| Dec 31, 2022 | 26.44% |
| Sep 30, 2022 | -36.72% |
| Jun 30, 2022 | -34.71% |
| Mar 31, 2022 | -38.02% |
| Dec 31, 2021 | -9.68% |
| Sep 30, 2021 | -20.07% |